Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants
Cardiovascular and Cerebrovascular Responses to Cardio-respiratory Events in Very Preterm Infants During the Transitional Period
1 other identifier
observational
42
1 country
1
Brief Summary
Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory events (CRE) are very frequent in preterm infants and may result in transient hypoxia and hypoperfusion of target organs, with possible clinical implications. The hemodynamic instability that characterizes the first 72 hours of life, also called as transitional period, place preterm infants at high risk of complications and may contribute to enhance fluctuations in end-organ perfusion and oxygenation induced by CRE. In this study we aimed to explore cardiovascular and cerebrovascular changes determined by different CRE types in preterm infants during the transitional period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2018
CompletedFirst Submitted
Initial submission to the registry
November 29, 2019
CompletedFirst Posted
Study publicly available on registry
December 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2020
CompletedJanuary 29, 2020
January 1, 2020
1.9 years
November 29, 2019
January 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Increase/reduction of cTOI during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage cTOI changes (cTOI at baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Increase/reduction of cFTOE during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage cFTOE changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Increase/reduction of cTHI during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage cTHI changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Increase/reduction of CO during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage CO changes (CO at baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life72 hours
Increase/reduction of SV during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage SV changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Increase/reduction of ICON during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage ICON changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Increase/reduction of SVR during isolated desaturation, isolated bradycardia and desaturation-bradycardia
Comparison of percentage SVR changes (baseline/during the event) among isolated desaturation, isolated bradycardia and desaturation-bradycardia
0-72 hours of life
Secondary Outcomes (2)
Effect of neonatal characteristics on cerebrovascular parameters
0-72 hours of life
Effect of neonatal characteristics on cardiovascular parameters
0-72 hours of life
Eligibility Criteria
Preterm infants on spontaneous breathing during the transitional period (0-72 hours of life).
You may qualify if:
- gestational age \<32 weeks' gestation AND/OR birth weight \<1500 g
You may not qualify if:
- major congenital malformations
- congenital heart disease
- mechanical ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
S. Orsola-Malpighi University Hospital
Bologna, Emilia-Romagna, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luigi Corvaglia, MD
S. Orsola-Malpighi University Hospital, Bologna, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Neonatal Consultant
Study Record Dates
First Submitted
November 29, 2019
First Posted
December 3, 2019
Study Start
February 22, 2018
Primary Completion
December 31, 2019
Study Completion
January 3, 2020
Last Updated
January 29, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share